| 11 AKI biomarkers are poor discriminants HJ de Grooth, JJ Parienti, M Schetz VU Research Portal 44 (7), 177, 2018 | | 2018 |
| 145-Does an adherence-enhancing program increase retention in care in the Swiss HIV Cohort S Kamal, TR Glass, A Calmy, MT Lecompte, O Bugnon, JJ Parienti, ... IAPAC, Miami, FL, USA, 2017 | 3 | 2017 |
| 18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: a multicenter cohort of 130 patients H de Boysson, E Liozon, M Lambert, JJ Parienti, N Artigues, L Geffray, ... Medicine 95 (26), e3851, 2016 | 101 | 2016 |
| 637 PRE-THERAPEUTIC ANXIODEPRESSIVE STATUS IS PREDICTIVE OF COMPLETION OF TREATMENT BY PEG-INTERFERON ALFA 2B AND RIBAVIRIN IN CHRONIC HEPATITIS C AL Bretagne, I Ollivier-Hourmand, C Guillemard, C Cognard, F Chastang, ... Journal of Hepatology, S234, 2009 | | 2009 |
| A clinical and EEG scoring system that predicts early cortical response (N20) to somatosensory evoked potentials and outcome after cardiac arrest C Daubin, D Guillotin, O Etard, C Gaillard, D du Cheyron, M Ramakers, ... BMC Cardiovascular Disorders 8, 1-9, 2008 | 34 | 2008 |
| A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication R Masson, V Colas, JJ Parienti, P Lehoux, M Massetti, P Charbonneau, ... Resuscitation 83 (11), 1413-1417, 2012 | 182 | 2012 |
| A head‐to‐head comparison of three coronary fractional flow reserve measurement technologies: the fractional flow reserve‐device study F Beygui, A Lemaitre, M Bignon, J Wain‐Hobson, C Briet, P Ardouin, ... Catheterization and Cardiovascular Interventions 95 (6), 1094-1101, 2020 | 8 | 2020 |
| A paradigm shift to prevent nosocomial infection:“Take a bath before I touch you” JJ Parienti Critical care medicine 37 (6), 2097-2098, 2009 | 1 | 2009 |
| A pilot study of tobacco screening and referral for smoking cessation program among HIV-infected patients in France JJ Parienti, Z Merzougui, A de La Blanchardière, S Dargère, P Feret, ... Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2017 | 10 | 2017 |
| A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill JF Timsit, M Rupp, E Bouza, V Chopra, T Kärpänen, K Laupland, T Lisboa, ... Intensive care medicine 44, 742-759, 2018 | 119 | 2018 |
| A-28 Manifestations neurologiques de l'endocardite infectieuse: A propos de 33 cas F Sarazin, JJ Parienti, S Dargère, C Marchand, R Leclercq, E Saloux, ... Medecine et Maladies Infectieuses, S136, 2004 | | 2004 |
| Ability of procalcitonin to distinguish between bacterial and nonbacterial infection in severe acute exacerbation of chronic obstructive pulmonary syndrome in the ICU C Daubin, F Fournel, F Thiollière, F Daviaud, M Ramakers, A Polito, ... Annals of Intensive Care 11, 1-8, 2021 | 8 | 2021 |
| Actualité de l’antibiothérapie inhalée dans les infections respiratoires à Pseudomonas aeruginosa C Aubron, C Rapp, JJ Parienti, O Patey Médecine et maladies infectieuses 32 (9), 460-467, 2002 | 7 | 2002 |
| Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference R Bellomo, C Ronco, RL Mehta, P Asfar, J Boisramé-Helms, M Darmon, ... Annals of intensive care 7, 1-40, 2017 | 175 | 2017 |
| Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial JJ Parienti, A Barrail-Tran, X Duval, G Nembot, D Descamps, M Vigan, ... Antimicrobial agents and chemotherapy 57 (5), 2265-2271, 2013 | 49 | 2013 |
| Adverse drug reaction reporting using a mobile device application by persons with multiple sclerosis: a cluster randomized controlled trial G Defer, S Fedrizzi, D Chevanne, F Montastruc, AR Briant, JJ Parienti, ... Drug Safety 44, 223-233, 2021 | 11 | 2021 |
| AH GLASSMAN, CM O'CONNOR, RM CALIFF, K. SWEDBERG, P. SCHWARTZ, JT BIGGER, JR, KRR KRISHNAN, LT VAN ZYL, JR SWENSON MS FINKEL, C LANDAU, PA SHAPIRO, CJ PEPINE, J MARDEKIAN, ... Journal of the American Medical Association 288 (5), 667, 2002 | | 2002 |
| AKI biomarkers are poor discriminants for subsequent need for renal replacement therapy, but do not disqualify them yet HJ de Grooth, JJ Parienti, M Schetz Intensive care medicine 44, 1156-1158, 2018 | 11 | 2018 |
| Alcoholic povidone-iodine to prevent central venous catheter colonization: a randomized unit-crossover study JJ Parienti, D du Cheyron, M Ramakers, B Malbruny, R Leclercq, ... Critical care medicine 32 (3), 708-713, 2004 | 136 | 2004 |
| Aldoscore to predict postoperative atrial fibrillation after cardiac surgery: external validation in a Japanese cohort J Alexandre, A Sezai, S Allouche, MO Fischer, F Beygui, JJ Parienti, ... Journal of Hypertension 35 (10), 2115-2116, 2017 | 3 | 2017 |
